Treatment Clinical Practice in Bipolar Depression in Spain
NCT ID: NCT00757328
Last Updated: 2009-02-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
378 participants
OBSERVATIONAL
2008-07-31
2008-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predictors of Recurrence in Bipolar Disorder in Spain
NCT00690859
Epidemiological Study to Evaluate Adherence to Treatment in Bipolar Disorder: Adherence Study
NCT00927420
Depressive Symptoms in Acute Manic Episode
NCT00690248
Functional Assessment of Patients With Acute Bipolar Depression After 8 Months of Follow-up
NCT01255982
Evaluation of Sub-syndromal Symptoms After Acute Depressive Episode in Bipolar Disorder
NCT01663974
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Ambulatory bipolar I and II patients, clinically stabilized for at least the two months prior to recruitment and who had at least one acute episode (depressive, manic, hypomanic or mixed) within the year prior to recruitment.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Evolution of the bipolar diagnoses inferior to 10 years
* Having recorded in the patient's clinical history the clinical management of at least two bipolar depressive episodes
Exclusion Criteria
* To have taken part in other study in the last 6 months
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AstraZeneca Pharmaceuticals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Santander, Cantabria, Spain
Research Site
Donostia / San Sebastian, Guipuzcoa, Spain
Research Site
Santiago C., La Coruna, Spain
Research Site
Palma M, Mallorca, Spain
Research Site
Pamplona, Navarre, Spain
Research Site
Oviedo, Principality of Asturias, Spain
Research Site
Bilbao, Vizcaya, Spain
Research Site
Alicante, , Spain
Research Site
Almería, , Spain
Research Site
Badajoz, , Spain
Research Site
Barcelona, , Spain
Research Site
Cadiz, , Spain
Research Site
Córdoba, , Spain
Research Site
Granada, , Spain
Research Site
Huesca, , Spain
Research Site
Las Palmas, , Spain
Research Site
León, , Spain
Research Site
Madrid, , Spain
Research Site
Málaga, , Spain
Research Site
Murcia, , Spain
Research Site
Seville, , Spain
Research Site
Valencia, , Spain
Research Site
Valladolid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-NES-DUM-2008/3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.